CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+13.82%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.5B
AUM Growth
+$378M
(+2.7%)
Cap. Flow
+$273M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
26.25%
Holding
738
New
61
Increased
261
Reduced
285
Closed
31
Top Buys
| 1 |
Visa
V
|
$77.8M |
| 2 |
Gilead Sciences
GILD
|
$59.3M |
| 3 |
Microsoft
MSFT
|
$46.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$40.2M |
| 5 |
Nu Holdings
NU
|
$39.1M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$112M |
| 2 |
Royal Bank of Canada
RY
|
$51.1M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$42.8M |
| 4 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$38.9M |
| 5 |
Merck
MRK
|
$33.3M |
Sector Composition
| 1 | Technology | 30.32% |
| 2 | Healthcare | 28.88% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Financials | 8.52% |
| 5 | Industrials | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Synchrony
SYF
$28.3B
| $15M | 0.1% |
392,146
-248,764
| -39% | -$9.5M |
|
202
Snowflake
SNOW
$72.6B
| $15M | 0.1% |
75,179
+49,361
| +191% | +$9.82M |
|
203
Quanta Services
PWR
$55.9B
| $14.9M | 0.1% |
69,058
+58,254
| +539% | +$12.6M |
|
204
Halliburton
HAL
$18.8B
| $14.8M | 0.1% |
410,428
+341,261
| +493% | +$12.3M |
|
|
DFS
205
DELISTED
Discover Financial Services
DFS
| $14.8M | 0.1% |
131,775
-7,553
| -5% | -$849K |
|
206
Cardinal Health
CAH
$36.1B
| $14.6M | 0.1% |
145,045
+8,001
| +6% | +$807K |
|
207
Bruker
BRKR
$4.46B
| $14.5M | 0.1% |
197,978
+58,792
| +42% | +$4.32M |
|
208
Legend Biotech
LEGN
$6.43B
| $14.5M | 0.1% |
241,032
+10,000
| +4% | +$602K |
|
209
Dover
DOV
$24.1B
| $14.5M | 0.1% |
94,253
+1,200
| +1% | +$185K |
|
210
Clean Harbors
CLH
$13B
| $14.5M | 0.1% |
82,807
+26,724
| +48% | +$4.66M |
|
211
MINISO
MNSO
$7.39B
| $14.3M | 0.1% |
701,573
-742,577
| -51% | -$15.1M |
|
212
Walmart
WMT
$800B
| $14.2M | 0.1% |
270,366
+24,855
| +10% | +$1.31M |
|
213
Quest Diagnostics
DGX
$20.1B
| $14.2M | 0.1% |
102,847
-16,875
| -14% | -$2.33M |
|
214
IDEAYA Biosciences
IDYA
$2.25B
| $14.1M | 0.1% |
395,019
-35,000
| -8% | -$1.25M |
|
215
Iovance Biotherapeutics
IOVA
$778M
| $14M | 0.1% |
1,727,822
-1,020,031
| -37% | -$8.29M |
|
216
General Mills
GIS
$26.7B
| $13.7M | 0.09% |
210,911
-84,740
| -29% | -$5.52M |
|
217
ZTO Express
ZTO
$14.5B
| $13.6M | 0.09% |
637,100
-838,010
| -57% | -$17.8M |
|
218
Liberty Media Series C
FWONK
$24.9B
| $13.4M | 0.09% |
+212,693
| New | +$13.4M |
|
219
PNC Financial Services
PNC
$81.2B
| $13.3M | 0.09% |
86,156
-50,709
| -37% | -$7.85M |
|
220
GE Aerospace
GE
$298B
| $13.3M | 0.09% |
130,189
+4,937
| +4% | +$503K |
|
221
Dell
DELL
$85.3B
| $13M | 0.09% |
169,752
+49,940
| +42% | +$3.82M |
|
222
Veralto
VLTO
$26.3B
| $12.7M | 0.09% |
+154,182
| New | +$12.7M |
|
223
Guardant Health
GH
$7.47B
| $12.6M | 0.09% |
466,137
-25,000
| -5% | -$676K |
|
224
Celldex Therapeutics
CLDX
$1.51B
| $12.6M | 0.09% |
317,509
-5,000
| -2% | -$198K |
|
225
Ascendis Pharma
ASND
$12.2B
| $12.5M | 0.09% |
99,375
-40,000
| -29% | -$5.04M |
|